RNU7-96P

Across TCGA pan-cancer cohorts, RNU7-96P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RNU7-96P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RNU7-96P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU7-96P expression acts as an unfavorable survival marker, although some lineages such as STAD show a favorable association.

ACC, THCA, and STAD are the cancer types where RNU7-96P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	III,IV	0.010	0.458	<.001	63	view →
THCA	OS	Tertile	All	0.905	0.996	<.001	51	view →
STAD	DFS	Tertile	III,IV	0.724	0.546	.016	20	view →
BLCA	OS	Tertile	All	0.154	0.591	.037	18	view →
PCPG	OS	Tertile	All	0.505	0.946	<.001	18	view →
ESCA	OS	Tertile	IV	0.243	0.590	.046	12	view →
TGCT	DFS	Tertile	All	0.127	0.685	.027	12	view →
GBM	DFS	Tertile	All	0.074	0.292	<.001	9	view →
SARC	OS	Tertile	All	0.188	0.597	.042	6	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RNU7-96P–ACC (DFS)

Open the ACC breakdown →